BUY Dr. Reddy's Laboratories — Nirav Chheda, 11 Sept 2026

byNirav Chheda, Nirmal Bang SecuritiesHorizon: NA (inferred Swing (≤2wk))11 Sept 2026via Zee Business (Live)

Entry₹1,177Inferred

Target₹1,250

Stop loss₹1,150-2.29% risk

Exit₹1,15015 Sept 2026, 1:35 pm

Stop-loss hit-2.29%

Follow Nirav Chheda for new calls(21% target hit, 71 closed calls)Get alerts Watch DRREDDY for new buy/sell callsGet alerts See 3 active Swing calls on DRREDDY See 182 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 15 Sept 2026

3 supporting1 opposing

Supports the BUY call (3)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·12 Sept · 2d ago

Dr Reddy's Mexico API facility gets 2 observations in US FDA records assessment

NewsCnbc-Tv18·11 Sept · 3d ago

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·11 Aug · 1mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY

NewsGoogle News·10 Sept · 4d ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Dr. Reddy's Laboratories Limited — Nirav Chheda, Nirmal Bang Securities

AI Assessment